Author

U.-M. Haltia

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Assay:spatial transcriptomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

S. Hautaniemi· 3 shared A. Farkkila· 2 shared A. Szabo· 2 shared A. Virtanen· 2 shared E. P. Erkan· 2 shared F. Perez-Villatoro· 2 shared I. Niemiec· 2 shared J. Hynninen· 2 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

S. Hautaniemi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Chemotherapy induces myeloid-driven spatial T-cell exhaustion in ovarian cancer

I.-M. P. Launonen, E. P. Erkan, I. Niemiec, A. Junquera, M. Hincapie-Otero, D. Afenteva, Z. Liang, M. Salko, A. Szabo, F. Perez-Villatoro, M. M. Falco, Y. Li, G. Micoli, A. Nagaraj, U.-M. Haltia, , A. Farkkila

This study shows chemotherapy causes myeloid-driven spatial T-cell exhaustion in ovarian cancer by altering immune cell states and interactions, suggesting new immunotherapy approaches.

bioRxiv · Mar 19, 2024 · PreprintCancer Biology

Patient-derived functional immuno-oncology platform identifies responders to ATR inhibitor and immunotherapy combinations in ovarian cancer

A. S. Nagaraj, M. Salko, A. Sirsikar, E. P. Erkan, E. A. Pietilä, I. Niemiec, J. Bao, G. Marchi, A. Szabo, K. Nowlan, S. Pikkusaari, A. Kanerva, J. Tapper, R. Koivisto-Korander, L. Kauppi, , A. Färkkilä

bioRxiv · Feb 15, 2024 · PreprintCancer Biology

Optimized detection of allelic imbalances specific for homologous recombination deficiency improves the prediction of clinical outcomes in cancer

F. Perez-Villatoro, J. Oikkonen, J. Casado, A. Chernenko, D. C. Gulhan, M. Tumiati, Y. Li, K. Lavikka, S. Hietanen, J. Hynninen, U.-M. Haltia, J. S. Tyrmi, H. Laivuori, P. Konstantinopoulos, S. Hautaniemi, , A. Farkkila

The paper develops a tumor-specific method to detect allelic imbalances for HRD prediction, showing improved clinical outcome prediction in ovarian and breast cancers.

bioRxiv · Aug 19, 2021Cancer Biology